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Store-operated Ca2+ channels activated by the
depletion of Ca2+ from the endoplasmic reticulum
(ER) are a major Ca2+ entry pathway in nonexcitable
cells and are essential for T cell activation and adap-
tive immunity. After store depletion, the ER Ca2+
sensor STIM1 and the CRAC channel protein Orai1
redistribute to ER-plasma membrane (PM) junctions,
but the fundamental issue of howSTIM1 activates the
CRAC channel at these sites is unresolved. Here, we
identify a minimal, highly conserved 107-aa CRAC
activation domain (CAD) of STIM1 that binds directly
to the N and C termini of Orai1 to open the CRAC
channel. Purified CAD forms a tetramer that clusters
CRAC channels, but analysis of STIM1 mutants
reveals that channel clustering is not sufficient for
channel activation. These studies establish a molec-
ular mechanism for store-operated Ca2+ entry in
which the direct binding of STIM1 to Orai1 drives
the accumulation and the activation of CRAC chan-
nels at ER-PM junctions.
INTRODUCTION
Store-operated Ca2+ channels, or SOCs, comprise the major
receptor-activated Ca2+ entry pathway in nonexcitable cells
and play important roles in the control of gene expression, cell
differentiation, secretion, and Ca2+ homeostasis (Parekh and
Putney, 2005). In their native environment, SOCs are activated
by the stimulation of phospholipase C (PLC)-coupled receptors
that generate inositol 1,4,5-trisphosphate (IP3) and release
Ca2+ from the endoplasmic reticulum (ER). The defining feature876 Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc.of SOCs is that they are activated by the reduction of [Ca2+]ER
rather than by receptor-associated signaling molecules, such
as G proteins, PLC, or IP3. The best-characterized store-oper-
ated channel is the Ca2+ release-activated Ca2+ (CRAC) channel,
whose activation is a steep function of [Ca2+]ER (Luik et al., 2008;
Prakriya and Lewis, 2004). CRAC channels play essential roles in
T lymphocytes and mast cells, where they provide the pathway
for Ca2+ entry triggered by antigen recognition or allergens,
respectively, and are required for T cell activation and mast
cell degranulation (Feske et al., 2001, 2005; Partiseti et al.,
1994; Vig et al., 2008).
The molecular mechanism by which ER Ca2+ depletion acti-
vates the CRAC channel has been a mystery since the original
proposal of the store-operated Ca2+ entry (SOCE) hypothesis
over 20 years ago (Prakriya and Lewis, 2004; Putney, 1986).
However, remarkable progress has been made in the past
several years after the identification of STIM1 as the ER Ca2+
sensor (Liou et al., 2005; Roos et al., 2005; Zhang et al., 2005)
and Orai1 as the pore-forming subunit of the CRAC channel
(Prakriya et al., 2006; Vig et al., 2006; Yeromin et al., 2006).
Recent studies show that the loss of ER Ca2+ triggers the oligo-
merization of STIM1 (Liou et al., 2007; Muik et al., 2008; Statho-
pulos et al., 2006) and its accumulation in regions of the
ER located within 10–25 nm of the plasma membrane (Wu
et al., 2006), commonly referred to as ‘‘puncta.’’ Orai1 accumu-
lates in overlying regions of the plasma membrane (PM) in
register with STIM1 (Luik et al., 2006; Xu et al., 2006), culminating
in the local entry of Ca2+ through CRAC channels (Luik et al.,
2006). A recent study shows that STIM1 oligomerization is the
key event that triggers the redistribution of STIM1 and Orai1,
translating changes in [Ca2+]ER into graded activation of the
CRAC channel (Luik et al., 2008).
While these studies demonstrate that STIM1 and Orai1 redis-
tribute to ER-PM junctions after depletion of the internal stores, it
is still not clear how this occurs. STIM1 forms puncta in response
to store depletion even when expressed in the nominal absence
of Orai1 (Xu et al., 2006), suggesting that its initial target may be
independent of Orai1. In contrast, Orai1 only forms puncta in
store-depleted cells when coexpressed with STIM1, suggesting
that it becomes trapped at ER-PM junctions by binding to STIM1
or an associated protein (Xu et al., 2006). Several parts of the
cytosolic domain of STIM1, including the C-terminal polybasic
domain, an ERM-like domain, and a serine-proline-rich domain,
have been implicated in the activation of Orai1, but their specific
roles and interactions in these localization events are not under-
stood (Baba et al., 2006; Huang et al., 2006; Li et al., 2007; Liou
et al., 2007).
The molecular mechanism by which STIM1 activates the
CRAC channel has also been controversial. A widely consid-
ered ‘‘diffusible messenger’’ model posits that STIM1 oligomer-
ization promotes the synthesis of a ‘‘Ca2+ influx factor’’ (CIF)
that is delivered locally at ER-PM junctions to stimulate iPLA2b
to produce lysolipids that activate ICRAC (Bolotina, 2008). An
alternative ‘‘conformational coupling’’ hypothesis (Berridge,
1995) proposes that STIM1 binds physically to the CRAC
channel or to an associated protein to activate Ca2+ entry.
Precisely how this binding event might activate the channel is
unclear; possible mechanisms include the linking of Orai1
dimers to form active tetrameric channels, or the allosteric acti-
vation of resting tetramers (Ji et al., 2008; Penna et al., 2008).
The conformational coupling model gains indirect support
from the precise colocalization of STIM1, Orai1, and open
CRAC channels at ER-PM junctions (Luik et al., 2006; Wu
et al., 2006) and fluorescence resonance energy transfer
(FRET) between labeled STIM1 and Orai1 after store depletion
(Muik et al., 2008; Navarro-Borelly et al., 2008). In addition,
the cytosolic domain of STIM1 (CT-STIM1) expressed in soluble
form accumulates at the PM in an Orai1-dependent manner and
activates ICRAC (Huang et al., 2006; Muik et al., 2008; Zhang
et al., 2008), providing indirect evidence that Orai and STIM1
form a protein complex. Coimmunoprecipitation studies have
been somewhat equivocal, with STIM1 and Orai1 reported to
coimmunoprecipitate after store depletion (Yeromin et al.,
2006), before store depletion (Vig et al., 2006), or not at all
(Gwack et al., 2007). However, coimmunoprecipitation experi-
ments are limited in that they cannot distinguish direct binding
of STIM1 to Orai1 from the formation of multiprotein complexes.
There is currently no definitive evidence demonstrating a direct
interaction between STIM1 and Orai1.
In this study we identify two functional domains of STIM1
involved in the formation of active STIM1-Orai1 complexes.
The C-terminal polybasic domain of STIM1 is required for
STIM1 targeting to ER-PM junctions in the nominal absence of
Orai1. In addition, a 107 residue CRAC activation domain
(CAD) in STIM1 binds directly to the N and C termini of Orai1.
Mutant STIM1 proteins that lack the CAD or contain mutations
in the CAD show that this domain is necessary and sufficient to
cluster and activate CRAC channels, andmutant STIM1 proteins
also demonstrate that CRAC-channel clustering and activation
are functionally separable events. These results establish that
the direct binding of STIM1 to Orai1 is the driving mechanism
for both the redistribution and activation of CRAC channels in
response to Ca2+ store depletion.RESULTS
STIM1 Accumulates at ER-PM Junctions
by Orai1-Dependent and -Independent Mechanisms
We initially investigated whether the formation of puncta by
STIM1 and Orai1 after depletion of stores depends on coexpres-
sion of both proteins. When expressed by itself in HEK293 cells,
mCherry-labeled STIM1 (mCh-STIM1) formed distinct puncta
after depletion of Ca2+ stores with thapsigargin (TG; Figure 1A).
In contrast, eGFP-myc-Orai1 expressed alone did not form
puncta in response to TG (Figure 1B), but coexpression of
mCh-STIM1 restored its ability to form puncta (Figure 1C). These
results suggest that STIM1 recruitment to ER-PM junctions is
independent of Orai1, whereas Orai1 recruitment to these sites
depends on binding to STIM1 or a STIM1-associated protein,
as has been previously suggested (Xu et al., 2006).
To identify the regions of STIM1 that are necessary for puncta
formation, we investigated the role of the polybasic C-terminal
domain (aa 672–685). Deletion of this region (STIM1-DK) has
been reported to prevent puncta formation and SOC activation
in some studies (Huang et al., 2006; Liou et al., 2007) but not in
others (Li et al., 2007). We found that STIM1-DK failed to form
puncta after store depletion when expressed alone in HEK293
cells (Figure 1D); however, when expressed together with
Orai1, both proteins colocalized in puncta and activated ICRAC
after store depletion (Figures 1E and 1F). These data suggest
that the polybasic domain is required to localize STIM1 to
ER-PM junctions in the absence of Orai1 but that a second
domain recruits and activates Orai1 at these sites.
Identifying a Minimal Cytosolic Region of STIM1
that Opens the CRAC Channel
To identify the CRAC-activating domain of STIM1, we first tested
a series of soluble cytosolic STIM1 fragments for their ability to
activate an NFAT-dependent luciferase reporter gene (NFAT-
luc). A series of constructs were generated by progressive trun-
cation of the full-length cytosolic region of STIM1 (Figure 2A;
STIM1234–685; CT-STIM1) and were transiently expressed in
a HEK293T cell line containing NFAT-luc. Because NFAT-
dependent transcription requires the sustained elevation of intra-
cellular Ca2+ ([Ca2+]i) combined with a phorbol ester to activate
protein kinase C, treatment of cells bearing only NFAT-luc with
PMA (phorbol 12-myristate 13-acetate; 1 mM) does not stimulate
luciferase production. However, PMA in conjunction with 1 mM
thapsigargin (TG), which activates Ca2+ entry through endoge-
nous CRAC channels, activates NFAT-luc robustly (Figure 2B).
Therefore, we compared luciferase production in the presence
of PMAwith that in PMA + TG to assess the ability of STIM1 frag-
ments to activate endogenous CRAC channels.
While CT-STIM1 did not activate the NFAT reporter gene with
PMAalone, truncations of either theCorN terminusof this protein
generated several active STIM1peptides (D3,D5,D6). Bymaking
additional truncations, we identified STIM1342–448 (D5) as the
minimal peptide that was sufficient to activate NFAT-luc; we
will refer to this domain hereafter as the CRAC activation domain
(CAD). Western analysis showed that the inactivity of peptides
D1, D2, D4, and D7–9 was not due to inadequate expression
(Figure S1A available online). The CAD encompasses a putativeCell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc. 877
Figure 1. Deletion of the STIM1 Polybasic Domain Distinguishes Orai1-Dependent and -Independent Mechanisms of STIM1 Accumulation at
ER-PM Junctions
(A) Wild-type mCh-STIM1 expressed alone in HEK293 cells redistributes from a diffuse ER distribution (Rest) to the cell periphery after store depletion with
TG (0 Ca + TG). After depletion, puncta are visible at the cell footprint.
(B) eGFP-myc-Orai1 when expressed alone does not redistribute into puncta after depletion.
(C) When expressed together, STIM1 and Orai1 form colocalized puncta after store depletion.
(D and E) Unlike wild-type STIM1, STIM1-DK expressed alone fails to form puncta (D); however, when coexpressed with Orai1, both proteins form colocalized
puncta after store depletion (E).
(F) Store depletion activates ICRAC in HEK293 cells expressing STIM1-DK and Orai1 demonstrating that the polybasic region is not essential for ICRAC activation.
All images were taken of cell footprints with confocal microscopy. Scale bars represent 10 mm.coiled-coil and part of the ERM domain of STIM1, is highly
conserved among vertebrates and invertebrates fromC. elegans
to H. sapiens, and is virtually identical to a sequence in STIM2,
another ER Ca2+ sensor that controls CRAC channel activation
(Brandman et al., 2007) (Figure S2).
To determine whether CAD activates store-operated Ca2+
influx in cells, we measured [Ca2+]i in HEK293 cells expressing
CAD and Orai1. CAD evoked a sustained [Ca2+]i elevation that
was dependent on extracellular Ca2+ (Figure 2C), was sup-
pressed by CRAC channel inhibitors like 2-APB and 10 mM
La3+ (Figures S3A and S3B), and was not observed in cells coex-
pressing a dominant-negative nonconductive Orai1 mutant,
Orai1E106A (Prakriya et al., 2006) (Figure 2C). Importantly, CAD878 Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc.activated Ca2+ entry without depleting intracellular stores,
because the Ca2+ released by TG in Ca2+-free media was similar
in CAD-expressing and untransfected cells (Figure 2C). These
results suggest that CAD elevates [Ca2+]i by activating CRAC
channels independently of store depletion.
As a definitive test for CRAC channel activation, we conducted
whole-cell patch clamp recordings fromHEK293 cells transiently
transfected with myc-Orai1 and either YFP-STIM1 or YFP-CAD.
In cells expressing full-length YFP-STIM1, ICRAC appeared
over several minutes after break-in, consistent with the typical
slow activation seen in response to passive store depletion
(Figure 2D). ICRAC showed the characteristic inwardly rectifying
current-voltage relation (Figure 2D, right), inhibition by La3+,
and modulation by 2-APB. In contrast, inward current was
present from the moment of break-in in cells expressing YFP-
CAD (Figure 2E). This current was identified as ICRAC on the basis
of its dependence on extracellular Ca2+, inward rectification,
sequential enhancement and inhibition by 2-APB, and inhibition
by La3+ (Figure 2E and Figures S3C and S3D). ICRAC was not
observed at break-in in HEK293 cells transfected with YFP or
YFP-CAD in the absence of Orai1 (Figure 2F), consistent with
the low level of endogenous STIM1 and Orai1 in these cells.
Interestingly, the current activated by CAD differed from native
ICRAC in that it lacked fast Ca
2+-dependent inactivation (Zweifach
and Lewis, 1995). Inactivation was restored by addition of STIM1
residues carboxy-terminal to CAD (F.M.M., C.Y.P., R.E.D., and
R.S.L., unpublished data).
Transfection of HEK293 cells with YFP-CT-STIM1 + myc-
Orai1 failed to activate constitutive ICRAC (Figure 2F) or elevate
resting [Ca2+]i (data not shown), consistent with the lack of
activity in the NFAT-luciferase assay. CT-STIM1 was inactive
even though it was expressed at comparable levels to CAD or
wild-type STIM1 (WT-STIM1; Figure S1B). While coexpression
of CT-STIM1 + Orai1 did not elevate resting [Ca2+]i in HEK293
cells, it did so in HEK293T cells, which express large T antigen
and express exogenous proteins at substantially higher levels
than do HEK293 cells (data not shown). Our studies demonstrate
that CAD is a much more potent activator of Orai1 than
CT-STIM1, based on its ability to activate ICRAC comparably to
WT-STIM1 at expression levels at which CT-STIM1 activity is
undetectable (Figure 2F).
CAD Associates with Orai1 In Vivo and In Vitro
Because cytosolic CAD is a potent activator of Orai1 channels
and is not associated with the ER, we hypothesized that CAD
might bind to Orai1. To test this idea, we first expressed YFP-
CAD with or without myc-Orai1 in HEK293 cells and examined
its intracellular localization. In the absence of Orai1, YFP-CAD
was localized diffusely throughout the cytoplasm, but the intro-
duction of Orai1 led to a dramatic recruitment of YFP-CAD to
the plasma membrane, suggesting that the two proteins form
a complex (Figure 3A). To provide additional evidence that CAD
and Orai1 are part of the same protein complex, we expressed
Flag-tagged CAD and eGFP-tagged Orai1 in HEK293T cells
and immunoprecipitated CAD with anti-Flag antibodies. eGFP-
myc-Orai1 was detected in the immunoprecipitates from cells
coexpressing CAD and Orai1 but not from cells expressing CAD
or Orai1 alone (Figure 3B). The reciprocal experiment, in which
Flag-tagged Orai1 was immunoprecipitated with anti-Flag
antibodies and YFP-CAD was detected by western blotting,
confirmed that CAD coimmunoprecipitates with Orai1 only
when the two proteins are coexpressed (Figure 3C). Thus, CAD
and Orai1 form a protein complex in mammalian cells. Under
the same conditions (150 mM salt, 1% Triton X-100), we were
unable to detect any interaction between CT-STIM1 and Orai1
(Figure 3D), suggesting that the affinity of the full-length cyto-
plasmic domain of STIM1 for Orai1 is much weaker than that of
the isolated CAD. This result may explain why CT-STIM1 is
such a weak activator of CRAC channels and suggests that
CAD is not exposed in CT-STIM1.As a third test for association of CAD and Orai1 in vivo, and
to map the interaction domains of Orai1, we introduced both
proteins into a yeast split ubiquitin interaction system (Tha-
miny et al., 2004). In this assay, interaction of the two test
proteins reunites the N- and C-terminal fragments of ubiquitin,
releasing a LexA-VP16 transcriptional activator that enters the
nucleus and activates reporter genes (Figure 3E). Fusion
proteins of Orai1 and the N-terminal fragment of ubiquitin
(NubG-Orai1) and of CAD and the C-terminal fragment of
ubiquitin linked to LexA-VP16 (CAD-Cub-LV) were introduced
into a yeast strain containing LexA His and b-galactosidase
reporter genes. Yeast containing both the NubG-Orai1 and
CAD-Cub-LV survived on His selection plates and produced
significant levels of b-gal, whereas yeast expressing NubG-
Orai1 and the Cub-LV domain alone did not (Figure 3F),
indicating that CAD and Orai1 interact with each other in
a heterologous system.
CAD Binds Directly to Orai1
To test for direct binding between the CAD and Orai1, we gener-
ated a GST-tagged CAD peptide in E. coli and an Orai1 protein
containing C-terminal octa-histidine and N-terminal EEYMPME
(‘‘EE’’) tags in insect Hi5 cells. We incubated purified GST-CAD
or GST alone with purified EE-Orai1-His8 and used glutathione
beads to precipitate the complexes. GST-CAD coprecipitated
Orai1, while GST alone did not, indicating that CAD binds directly
to Orai1 in vitro (Figure 4A).
To examine the size of the protein complexes generated by the
interaction of Orai1 and CAD, we prepared extracts from Hi5
cells expressing EE-Orai1-His8 alone or in combination with
CAD-His6 and analyzed them by size-exclusion chromatog-
raphy. Orai1 and CAD proteins were first affinity-purified with
Ni2+-NTA, and Orai1 was then immunoprecipitated with anti-
EE antibodies. Size-exclusion chromatography of Orai1 alone
revealed a monodisperse peak with an apparent mass of 290
kD (Figure 4B, left), consistent with Orai1 forming multimers in
the absence of CAD. Analysis of the eluate fractions by SDS-
PAGE revealed a doublet of37 kD (Figure 4B, right), represent-
ing glycosylated and unglycosylated forms of EE-Orai1-His8 as
determined by the ability of tunicamycin to collapse the top
band to the lower band (data not shown). In contrast to Orai1
alone, EE-Orai1-His8 purified from cells coexpressing CAD-
His6 eluted largely in the void volume, consistent with the forma-
tion of a large protein complex of molecular weight >10 MDa
(Figure 4C). The complex was stable in 0.5 M NaCl, suggesting
a high-affinity hydrophobic interaction of multiple CAD and
Orai1 proteins. Importantly, complex formation did not involve
significant amounts of additional proteins, indicating that the
interaction between CAD and Orai1 is direct (Figure 4C). The
excess free CAD-His6, isolated by gel filtration after Ni
2+-NTA
purification of the complex, was analyzed by multiangle light
scattering (MALS), which indicated a molecular weight of 58
kD, or 4.4 times the predicted weight of 13.2 kD for the CAD-
His6 monomer (Figure 4D). Together, these results show that
Orai1 exists as a multimer in the absence of CAD and that
CAD forms a tetramer in free solution that links together multiple
Orai1 multimers.Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc. 879
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STIM1-CAD Binds to the N and C Termini of Orai1
To identify regions of Orai1 important for activation by CAD, we
characterized the binding of CAD toOrai1 using two approaches.
First, we expressed fusions of NubGwith the N terminus, the II-III
cytoplasmic loop, and the C terminus of Orai1 in yeast together
with CAD-Cub-LV. Survival of colonies in selection media and
production of b-gal revealed that CAD binds to the N and C
terminus ofOrai1 but not to the II-III loop or to theCubiquitin frag-
ment alone (Figure 5A). Based on the level of b-gal activity, CAD
appears to interact with theOrai1 C terminuswith a higher affinity
than with the N terminus. We next expressed fusions of YFP with
the N terminus, the II-III loop, and the C terminus of Orai1 in
HEK293T cells together with Flag-myc-CAD. Immunoprecipita-
tion of Flag-myc-CAD followed by western blotting revealed
that CAD interacts with the N and C terminus of Orai1 but not
with the II-III loop (Figure 5B).
To explore the interaction between the N terminus of Orai1 and
CAD in more detail, we mapped the subregion within the
N terminus of Orai1 that is responsible for CAD binding, using
both the split ubiquitin and HEK293T coimmunoprecipitation
assays. In the yeast assay, CAD interacted strongly with
Orai148–91 and Orai168–91 but not with Orai148–70. Similarly, in
the HEK cell assay, CAD coimmunoprecipitated with Orai148–91
but not with Orai11–70, suggesting that CAD binds to the region
of aa 70–91 (Figure 5D). The interaction between CAD and
Orai148–91 was significantly stronger than that between CAD
and the full-length N terminus of Orai1 (Figure 5D, right), suggest-
ing that aa 1–48 reduce the affinity betweenCAD and the isolated
Orai1 N terminus.
We next tested the function of the CAD-binding regions of
Orai1 using whole-cell recording. We introduced CAD into
HEK293 cells together with Orai1 lacking the full N (Orai1-DN)
or C terminus (Orai1-DC) or the initial 73 residues of the
N terminus (Orai1-DN73) preceding the CAD binding site (Li
et al., 2007). Western blotting and immunostaining of Orai1 con-
taining an extracellular HA epitope confirmed that these muta-
tions do not alter the expression or cell surface localization of
the channels (Figure S4). CAD constitutively activated ICRAC in
cells expressing Orai1-DN73 but not in cells expressing Orai1-
DN or Orai1-DC (Figures 5E and 5F), showing that the N and C
termini of Orai1 are both necessary for activation by CAD but
that aa 1–73 are not absolutely required (see also Li et al.,
2007). Furthermore, deletion of aa 73–84 from Orai1 suppressed
CAD-induced Ca2+ influx (Figure S5). Taken together with the
results of Figures 5A–5D, these findings suggest that CAD
binding to the C terminus of Orai1 and the membrane-proximalregion of the Orai1 N terminus is required to activate the CRAC
channel.
CAD Clusters CRAC Channels
The large size of the CAD/Orai1 complex indicates that CAD
clusters Orai1. To investigate the nature of these complexes
and test for nonspecific aggregation, we examined purified
material from the gel filtration column by negative-stain single-
particle electron microscopy (Figures 6A and 6B). Analysis of
purified Orai1 alone revealed primarily particles of 8–10 nm in
diameter, presumably representing single CRAC channels, with
a low frequency of pairs and triplets. In contrast, in the presence
of CAD, we observed clusters of Orai1 unitary particles that
increased in frequency and sizewith increasingmolecular weight
of the column eluates. Taken together with the MALS results,
these images suggest that tetramers of CAD bind to multiple
sites on CRAC channels to create these clusters.
To test whether CAD also clusters CRAC channels in intact
cells, we conducted fluorescence recovery after photobleaching
(FRAP) experiments of eGFP-Orai1 expressed alone or with CAD
in HEK293 cells. Our FRAP measurements of eGFP-Orai1 alone
suggest that 83% ± 2% of the channels are mobile in the
membrane with an effective diffusion coefficient (D) of 0.070 ±
0.011 mm2/s (n = 9, Figures 6C–6E). In cells coexpressing eGFP-
Orai1 and CAD, the mobile fraction was unchanged (87% ± 4%),
but Orai1 diffusion was slowed by a factor of two (D = 0.036 ±
0.006 mm2/s, n = 6). Thus, CAD does not appear to anchor
CRAC channels to an immobile substrate, but does slow their
diffusion significantly, consistent with CAD-induced clustering of
Orai1 in the cell membrane.
The Role of CAD in Orai1 Binding and Activation
by STIM1
A key question is whether CAD is responsible for the clustering
and activation of CRAC channels by full-length STIM1 after store
depletion. To address this, we measured the ability of mCherry-
tagged STIM1 variants containing CAD mutations to cocluster
with eGFP-Orai1 and activate Ca2+ entry in response to TG
(Figure 7). STIM1-Orai1 colocalization was quantified as the
fraction of total STIM1 and Orai1 fluorescence that was recruited
to regions of high fluorescence covariance (Figure S6), while
Ca2+ influx was measured with single-cell Ca2+ imaging. For
each set of experiments, we measured mCherry and GFP fluo-
rescence to confirm that differences in the activity of the
various STIM1 constructs were not due to differences in expres-
sion level (Figure S7).Figure 2. Identification of CAD as a Potent CRAC Channel Activator
(A) Full-length STIM1 with its putative functional domains (top) and truncated versions of STIM1 (D1–D9; bottom) with the CAD shown in gray.
(B) NFAT-dependent luciferase activity in HEK293T (NFAT-Luc) cells transfected with wild-type (WT) or truncated (D1–D9) STIM1 constructs. Cells were treated
with 1mMPMAor 1mMTG+PMAas shown. D5 (CAD) is theminimal region that is necessary and sufficient to activateNFAT.Data are shownasmean±SEM (n= 4).
(C) CAD activates SOCE without depleting intracellular Ca2+ stores. Ca2+ measurements (mean ±SEM) in untransfected HEK293 cells (black; n = 28) and cells
expressing CAD + Orai1 (red; n = 15), CAD + Orai1E106A (gray; n = 17), or CAD (342-440) + Orai1 (blue; n = 12) is shown.
(D) Left: ICRAC develops slowly in a representative cell cotransfected with WT eGFP-STIM1 + myc-Orai1. Current recorded during brief pulses to 100 mV in
2 mM Ca2+o is plotted against time after break-in. Right: Characteristic I-V relationship for ICRAC recorded in 20 mM Ca
2+
o from the same cell.
(E) Left: ICRAC is constitutively active in a representative cell cotransfected with YFP-CAD + myc-Orai1. Current is plotted as in (D). Right: I-V relationship for the
CAD-induced current recorded in 20 mM Ca2+o from the same cell.
(F) Current densities in cells transfected with CAD or Orai1 alone or cotransfected with myc-Orai1 and eGFP-STIM1, YFP-CAD, or YFP-CT-STIM1. Current
measured at 100 mV during voltage ramps in 20 mM Ca2+o was normalized to the cell capacitance. Mean values ±SEM from four to five cells are shown.Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc. 881
Figure 3. CAD Associates with Orai1
(A) YFP-CAD is cytosolic when expressed by itself in a HEK293 cell (top) but accumulates at the cell perimeter when coexpressed with Orai1 (bottom). The scale
bar represents 10 mm.
(B and C) Western blots of cell lysates (left) or immunoprecipitated material (right) from cells expressing CAD, Orai1, or CAD + Orai1. Anti-Flag antibodies coim-
munoprecipitate GFP-myc-Orai1 with Flag-myc-CAD (B) and coimmunoprecipitate YFP-CAD with Flag-myc-Orai1 (C).
(D) CT-STIM1 does not coimmunoprecipitate with myc-Orai1 (representative of four experiments).
(E) Schematic depiction of the yeast split ubiquitin assay.
(F) CAD associates with Orai1 in the split ubiquitin assay. Yeast containing NubG-Orai1 and either Cub-LV alone or CAD-Cub-LV grow well on plates lacking tryp-
tophan and leucine but containing histidine (SD-TL). Only yeast expressing NubG-Orai1 andCAD-Cub-LV grow on plates lacking all three amino acids (SD-TLH) in
the absence or presence of 5mM3-aminotriazole (3AT), a competitive HIS3 inhibitor that increases the stringency of selection. Yeast containingCAD-Cub-LV and
NubG-Orai1 also activate LacZ, whereas cells expressing NubG-Orai1 and Cub do not. The homomeric interaction of Alg5 is shown as a positive control.We first deleted the CAD from WT-STIM1 (STIM1-DCAD) and
found that when expressed with eGFP-Orai1, mCh-STIM1-
DCAD failed to form puncta, cluster Orai1, or activate Ca2+ entry882 Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc.in response to TG (Figures 7A, 7E, and 7F). Moreover, in the
NFAT-luciferase assay, STIM1-DCAD inhibited NFAT activation
by endogenous channels after treatment with TG + PMA
Figure 4. CAD Binds Directly to Orai1
(A) Glutathione beads precipitate EE-Orai1-His8 with GST-CAD but not GST alone.
(B) Size-exclusion profile of purified EE-Orai1-His8 (left). On SDS-PAGE (right), peak fractions contain EE-Orai1-His8 as a pair of glycosylated and unglycosylated
bands at 37 kDa.
(C) Size-exclusion profile of EE-Orai1-His8 and CAD-His6 coexpressed in Hi5 cells and affinity purified in 0.5 M NaCl (left). Much of the CAD and Orai1 coelute in
the void volume (molecular weight >10 MDa) of the Superose 6 gel filtration column (fraction 4). On SDS-PAGE (right), the band corresponding to the dimer of
EE-Orai1-His8 (arrow) was identified by western blotting.
(D)Multiangle light scattering (MALS) indicates amolecularweight of58 kDa for purifiedCAD-His6, approximately four times thepredictedmass of themonomer.(Figure 2B), suggesting that it forms nonfunctional oligomers
with endogenous STIM1. These results show that the CAD is
required for STIM1 to form puncta and to recruit and activate
Orai1 at ER-PM junctions.
To test whether the CAD in STIM1 can function independently
of the residues C-terminal to it, we truncated STIM1 from the
C terminus to the end of the CAD (STIM11–448). When coex-
pressed with Orai1, STIM11–448 behaved much like WT-STIM1;
it was distributed throughout the ER of resting cells, and after
store depletion it formed puncta with Orai1 and activated Ca2+
entry (Figures 7B and 7E), though both puncta and Ca2+ entry
were somewhat less pronounced than with WT-STIM1
(Figure 7F). Therefore, the region of STIM1 carboxy terminal to
CAD is not absolutely required for CRAC channel binding or acti-
vation, although it may make a minor contribution to both.
Deletion of the last 8 aa from the CAD (342–440) peptide elim-
inates its ability to activate CRAC channels (Figure 2B, C). We
therefore tested whether this mutation also prevents STIM11–448
from activating Orai1 by deleting the final 8 aa to generate
STIM11–440. STIM11–440 failed to activate SOCEafter store deple-
tion (Figures 7E and 7F), supporting the idea that CAD function isrequired for CRAC channel activation by STIM1. Surprisingly,
however, STIM11–440 retained the ability to form puncta and
cluster Orai1, though to a lesser extent than WT-STIM1 (Figures
7C and 7F). Consistent with this result, coimmunoprecipitation
experiments revealed that the CAD 342–440 retained the ability
to bind to Orai1 (Figure S8) even though it cannot activate it.
We obtained a similar result with a STIM1 C437G mutant, which
formed pronounced puncta with Orai1 but only marginally acti-
vated SOCE (Figures 7D–7F). Together, these data indicate that
clustering of CRAC channels by itself is not sufficient to cause
channel opening.
DISCUSSION
The STIM1 Polybasic Domain Directs
Orai1-Independent Formation of STIM1 Puncta
Our results with STIM1-DK reveal a new role for the highly
conserved lysine-rich domain in STIM1 trafficking and resolve
the current debate about its necessity for CRAC channel activa-
tion. We found that while STIM1 can form puncta when
expressed alone, STIM1-DK requires coexpression of Orai1,Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc. 883
Figure 5. CAD Binds to Both the N and C Termini of Orai1
(A) In this split ubiquitin assay, b-gal production and growth of transformants on plates lacking histidine indicate a strong interaction between CAD and the
C terminus of Orai1, a weaker interaction with the N terminus, and lack of interaction with the II-III loop of Orai1.
(B) CAD in HEK293T cells coimmunoprecipitates with YFP-tagged N-terminal and C-terminal fragments of Orai1 but not with the II-III loop.
(C) Split ubiquitin assays showing that CAD interacts with aa 48–91 of the Orai1 N terminus; this appears to be due to binding to aa 68–91 rather than aa 48–70.
(D) CAD coimmunoprecipitates with Orai1-NT(48–91) but only very weakly with the entire N terminus of Orai1 (aa 1–91).
(E) Whole-cell recordings in 20mMCa2+o fromHEK293 cells coexpressing truncated Orai1-eGFP proteins and YFP-CAD. Deletion of the N or C terminus of Orai1
abrogates function, but a substantial level of ICRAC is generated by Orai1-DN73.
(F) Summaryof ICRACmeasurements (current at100mV,20mMCa2+o, normalized tocell capacitance)with the indicatedconstructs (four cells each,mean±SEM).showing that the polybasic domain enables STIM1 binding to an
Orai1-independent target at ER-PM junctions. These results
explain discrepancies in prior studies, where STIM1-DK failed
to redistribute when expressed alone in HEK293 or HeLa cells
(Huang et al., 2006; Liou et al., 2007) but did form puncta and
activate ICRAC when coexpressed with Orai1 in HEK293 cells
(Li et al., 2007). The latter finding is now explained by the direct
binding of the CAD domain in STIM1-DK to Orai1.
The existence of multiple mechanisms for targeting STIM1 to
ER-PM junctions is expected to enhance productive interactions
between STIM1 and Orai1 after Ca2+ store depletion. Because
endogenous levels of STIM1 and Orai1 are generally modest
and their interaction is restricted to ER-PM junctions, which
cover only 5% of the cell surface (Wu et al., 2006), the proba-884 Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc.bility that freely diffusing STIM1 andOrai1 proteins will encounter
and bind to each other is likely to be low under physiological
conditions. However, the initial recruitment of STIM1 to the
ER-PM junctions via the polybasic domain produces a high local
concentration of CAD sites beneath the plasma membrane,
increasing the likelihood that a diffusing CRAC channel will bind
to STIM1 and thereby enhancing the speed and extent of CRAC
channel activation.
CAD Is the Domain of STIM1 that Activates
the CRAC Channel
In previous studies, the STIM1 cytosolic region was truncated or
mutated to probe the functions of putative domains that had
been identified through bioinformatic analysis. Significantly, all
of the truncations that completely inhibit CRAC channel activa-
tion and prevent the formation of puncta eliminate all or part
of CAD (aa 342–448). These include the ‘‘delta-ERM’’ (deleted
aa 251–535) (Huang et al., 2006), ‘‘delta-ST’’ (aa 1–390) (Baba
et al., 2006), and ‘‘delta-C2’’ (aa 1–424) (Li et al., 2007) variants.
The inhibitory effects of these deletions can now all be ascribed
to a loss of CAD function rather than suggesting roles for the
ERM, serine-proline-rich, and polybasic domains in SOC activa-
tion. The CAD’s central role is further underscored by the potent
ability of CAD peptide and STIM11–448 to activate SOCE and by
the loss of STIM1 activity after deletion of CAD or the introduc-
tion of mutations that inhibit CAD function (Figure 7).
Heterologous expression of the full-length cytosolic STIM1
domain, CT-STIM1, has been reported to activate CRAC chan-
nels (Huang et al., 2006; Muik et al., 2008; Zhang et al., 2008).
In our studies, CT-STIM1 failed to bind to Orai1 or evoke detect-
able CRAC channel activity when expressed at moderate levels
at whichCADbound toOrai1 and strongly activated CRAC chan-
nels. We only observed an effect of CT-STIM1 when it was over-
expressed in HEK293T cells along with Orai1, suggesting that it
binds to Orai1 with very low affinity. The much-reduced activity
of CT-STIM1 relative to CAD suggests that the CAD may be
hidden within CT-STIM1 and that a conformational change
(perhaps caused by STIM1 oligomerization) is needed to expose
the CAD after store depletion.
CAD Binds Directly to Orai1 to Activate
the CRAC Channel
Since the discovery of STIM1 and Orai1 and the demonstration
that they cocluster at ER-PM junctions in response to store
depletion, there has been considerable interest and uncertainty
about howSTIM1 activates the CRAC channel across the narrow
10–25 nm ER-PM gap. Several possible mechanisms have been
proposed, including local release of a diffusible messenger
(Bolotina, 2008) or a physical interaction with Orai1 mediated
either directly or through unidentified auxiliary proteins (Muik
et al., 2008; Varnai et al., 2007; Yeromin et al., 2006). Our GST-
pulldown and coelution results with purified proteins provide
the first definitive evidence that CAD binds directly to Orai1
without the necessity for auxiliary partners. Furthermore, the
ability of CAD to activate CRAC channels throughout the cell
independently of ER Ca2+ depletion argues strongly against
the necessity for a diffusible messenger like CIF to be released
by depletion-induced changes in the STIM1 luminal domain
(Bolotina, 2008). Our results provide strong evidence for
a conformational coupling mechanism in which binding of the
STIM1 CAD to Orai1 induces conformational changes that lead
directly to opening of the CRAC channel.
CAD Interacts with Multiple Regions of Orai1
The N- and C-terminal domains of Orai1 have previously been
implicated in CRAC channel clustering and activation. Deletion
of the Orai1 C terminus or an L273S mutation in the C terminus
prevents STIM1 from clustering Orai1 and activating ICRAC,
whereas deletion of the N terminus does not affect clustering
but precludes channel activation (Li et al., 2007; Muik et al.,
2008; but see Takahashi et al., 2007). In addition, CT-STIM1
was shown to bind weakly to the isolated Orai1 C terminus butnot the N terminus in vitro (Muik et al., 2008). These studies
concluded that STIM1 interacts physically only with the Orai1
C terminus, with the N terminus being required for channel
gating. Our results from using yeast split ubiquitin and mamma-
lian cell coimmunoprecipitation assays confirm the strong
binding of CAD to the Orai1 C terminus but also demonstrate
an interaction with themembrane proximal part of the N terminus
(aa 70–91), a region that is required for ICRAC activation (Li et al.,
2007) (Figure 5F, Figure S5). Because CAD binds to two regions
of Orai1 that are essential for channel activation, we hypothesize
that CAD may provide the energy for CRAC channel gating by
bridging the N and C termini of the channel.
CAD-Induced Clustering of CRAC Channels
Is Independent of Activation
Purified CAD forms a tetramer in solution (Figure 4D) and can
cluster Orai1/CRAC channel particles into extended arrays
both in vivo and in vitro (Figure 6). This implies that each CAD
tetramer has at least two binding sites for Orai1 and each
CRAC channel at least two binding sites for CAD. A key question
is, does CRAC channel clustering itself deliver a signal for
channel activation? Recent data suggest that Drosophila STIM
dimerizes resting dimers of Orai in the plasma membrane to
create functional homotetrameric CRAC channels (Penna
et al., 2008). Our negative-stain electron microscopy data
show that human CAD induces the clustering of Orai1 particles
that are similar in size to pure Orai1 particles, which is inconsis-
tent with the merging of two Orai1 dimers to form a tetramer
(Figure 6A). While these differences may be species specific,
our data support the idea that the human CRAC channel has
a constant subunit stoichiometry (Ji et al., 2008) and that CAD
links multiple channels together. Furthermore, the ability of the
STIM1 truncation mutant (1–440) (and to a lesser extent the
C437G mutant) to cluster Orai1 at ER-PM junctions without acti-
vating the channel (Figure 7F) shows that clustering and activa-
tion are separable processes. Thus, CRAC channel clustering it-
self is not sufficient to induce opening, implying that CAD
operates through an allosteric mechanism to gate the CRAC
channel.
A Molecular Mechanism for CRAC Channel Activation
The results of this study together with previous data suggest the
followingmodel for the activation of Orai1 by STIM1. Depletion of
ER Ca2+ stores causes a conformational change in the luminal
EF-hand/SAM domain of STIM1 that leads to its oligomerization.
Oligomerization has two functional effects: first, it enables the
polybasic region to target STIM1 to ER-PM junctions, and
second, it causes a conformational change in STIM1 to expose
the CAD. The locally high concentration of exposed STIM1 CAD
at the junctions promotes binding to Orai1, creating a high-
avidity trap to accumulate diffusing CRAC channels and leading
to the formation of tightly colocalized STIM1-Orai1 clusters.
Finally, the binding of CAD alters the conformation of Orai1 to
drive the opening of CRAC channels and evoke Ca2+ entry.
More direct evidence for key steps, e.g., the structural basis of
STIM1 oligomerization and conformational changes accompa-
nying the exposure of the CAD and CRAC channel opening,
will be needed to test this model definitively.Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc. 885
Figure 6. CAD Links Multiple CRAC Channels to Form Clusters
(A) Negative-stain electron microscopy of purified EE-Orai1-His8 (left panel; fraction 8 from Figure 4B) or complexes of EE-Orai1-His8 and CAD-His6 (right panels;
fractions 4 and 8 from Figure 4C). Scale bars represent 100 nm (top) and 20 nm (bottom, enlargements from dashed boxes).886 Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc.
EXPERIMENTAL PROCEDURES
Cells and Transfection
HEK293 and HEK293T cells (ATCC) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) with GlutaMax (GIBCO, Carlsbad, CA), 10% fetal
bovine serum (FBS; Hyclone, Logan, UT), and 1% penicillin/streptomycin
(Mediatech, Hargrave, VA). A HEK293 cell line with an inducible eGFP-myc-
Orai1 was generated with the Flp-In T-REx system (Invitrogen, Carlsbad, CA)
and was maintained with 50 mg/ml hygromycin and 15 mg/ml blasticidin. Cells
were transfected at 90% confluency with 0.2–0.5 mg DNA using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
NFAT-Luciferase Assays
HEK293T cells were cotransfected with the indicated constructs and an NFAT
reporter gene (firefly luciferase gene C-terminal to a 4X-NFAT site from the IL-2
gene). Cotransfection with the Renilla luciferase gene (pRLTK) driven by the
TK promoter was used to control for cell number and transfection efficiency.
After 12–18hr, cellswere treatedwith acontrol dimethyl sulfoxide (DMSO) solu-
tion (mock), phorbol 12-myristate 13-acetate (PMA; 1 mM), or PMA + TG (1 mM)
for 8 hr. Assays were performed with the Dual Luciferase Reporter Assay
System (Promega). For each condition, luciferase activity was measured with
four samples taken from duplicate wells with a 96-well automated luminometer
(Turner Biosystems). Results are represented as the ratio of firefly to Renilla
luciferase activity.
Immunoprecipitation and Immunoblot Analysis
Transfected HEK293T cells (12–24 hr) were washed with phosphate-buffered
saline (PBS) and lysed in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton
X-100, and protease inhibitors. Lysates were spun at 12,000 rpm for 10 min,
and the supernatant was incubated with anti-Flag M2 agarose beads (Sigma),
or anti-myc antibody followed by IgG agarose beads (Pierce). Lysates and
immunoprecipitates were subjected to SDS-PAGE, probed with horseradish
peroxidase (HRP)-conjugated secondary antibody, and detected by enhanced
chemiluminescence (Pierce).
Split-Ubiquitin Yeast Two-Hybrid Assay
Screening was performed according to the manufacturer’s instructions (Dual-
systems Biotech). Transformed yeast were selected on media lacking Trp and
Leu (-TL). Interaction was observed by cell growth on plates lacking Trp, Leu,
and His (-TLH) in the presence of 3-aminotriazole (3-AT). Protein interactions
were also assessed bymeasuring lacZ activity with the chromogenic substrate
X-gal (5-bromo-4-chloro-3-indolyl-b-galactopyranoside).
GST Pulldown Assays
ForGSTpulldownassays, eitherGST-CAD (0.16mM)orGST (0.15mM)was incu-
bated with EE-Orai1-His8 (0.1 mM) for 1 hr in buffer containing: 20 mM Tris-HCl
(pH 8.0), 150 mM NaCl, 20 mM imidazole, and 1 mM dithiothreitol (DTT) with
protease inhibitors. After addition of glutathione sepharose, the beads were
centrifuged and washed with the above buffer, and the precipitated proteins
were elutedwith boiling SDS and analyzed by SDS-PAGEandwestern blotting.
Purification of EE-Orai1-His8
EE-Orai1-His8 and His6-CAD were integrated into baculoviruses and
expressed alone (Orai1) or together (Orai1 + CAD) in Hi5 cells (Invitrogen) for
48 hr at 28C. After cell lysis, membranes were solubilized by resuspension
in 1% DDM (n-dodecyl-b-D-maltoside; Anatrace, IL, USA). Protein was puri-
fied with Ni2+-NTA beads, and the eluted protein was then incubated withg-bind Protein G Sepharose beads and anti-EE antibody (Covance, CA,
USA) overnight at 4C and eluted with 1 mg/ml EE peptide (Anaspec, CA,
USA). DDM was maintained at 0.1%, and the NaCl concentration was 0.5 M
up to this purification step. The protein was then passed over a Superose
6 size exclusion column equilibrated in 20 mM Tris (pH 8), 150 mM NaCl,
10% glycerol, 0.02% DDM, and 0.004% CHS (cholesteryl hemisuccinate,
Tris salt) to remove aggregated material and EE peptide. Orai1 was more
than 98% pure as judged by SDS-PAGE analysis.
MALS Analysis of His6-CAD
His6-CADwas isolated from cells expressing His6-CAD and EE-Orai1-His8 and
analyzed by MALS with a DAWN EOS light-scattering system (Wyatt Tech-
nology, Santa Barbara, CA). The detector responses were normalized against
monomeric bovine serum albumin.
Electron Microscopy
EE-Orai1-His8 alone or copurified with His6-CADwas diluted to a final concen-
tration of 0.01 mg/ml in 20 mM Tris, 150 mM NaCl, and 0.02% DDM buffer
and was negatively stained with uranyl formate as described (Ohi et al.,
2004). Images were recorded with a Phillips CM-10 electron microscope
equipped with a tungsten filament operated at 100 kV. Images were taken at
a nominal magnification of 39,0003 and a defocus of 1.5 mm on a Gatan
1k 3 1k CCD camera.
Confocal Microscopy
Six hours after transfection,HEK293 cellswere plated onto sterilized coverslips
coated with poly-D-lysine andmaintained in complete DMEM for an additional
12–18 hr before imaging in Ringer’s solution containing: 155mMNaCl, 4.5 mM
KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM D-glucose, and 5 mM Na-HEPES
(pH 7.4). For depletion of stores, cells were treated with 1 mM TG in Ca2+-free
Ringer’s (preparedby substitution of 2mMMgCl2 and1mMethyleneglycol tet-
raacetic acid [EGTA] for CaCl2) for 10 min. eGFP and mCherry were excited
simultaneously at 488 and 594 nm, respectively, on a Leica SP2 AOBS inverted
confocal microscope equipped with a PL APO 1003/NA 1.4 oil immersion
objective. Fluorescence emission was collected at 615–840 nm (mCherry)
and 510–570 nm (eGFP). All experiments were performed at 22C–25C.
Fluorescence Recovery after Photobleaching
Inducible HEK293 cells were transiently transfected with mCh-CAD and main-
tained with 10 mM LaCl3 to suppress tonic Ca
2+ entry. After 15–16 hr, eGFP-
myc-Orai1 expression was induced with 1 mg/ml tetracycline in medium con-
taining LaCl3. Cells were rinsed with 2 mMCa
2+ Ringer’s solution at 24 hr after
transfection prior to imaging on the confocal system described above. Pre-
bleach and recovery images were scanned at 488 nm at low power (20 mW
Ar laser, 50% power, 6% transmission). A 3 mm strip was bleached at 50%
laser power with full transmission for 2 s. Bleaching during the recovery
period was negligible (<5%). FRAP recovery curves were analyzed as
described (see the Supplemental Experimental Procedures).
Ca2+ Imaging
For Figure 2, cells were loaded at 37C in DMEM with 1 mM fura-2/AM for
30 min. Ratiometric Ca2+ imaging was performed at 340 and 380 nm in
2mMCa2+ Ringer’s solution with a Nikon Eclipse 2000-U inverted microscope
equippedwith a fluorescent arc lamp, excitation filter wheel, and aHamamatsu
Orca CCD camera. Images were collected with Openlab (Improvision) and
analyzed with Igor Pro.(B) Quantitation of cluster sizes for each condition shown in (A): Orai1 (n = 174) and Orai1 + CAD (fr 8, n = 134; fr 4, n = 90). Each histogram is normalized to its
maximum bin value.
(C) FRAP of HEK293 cells expressing eGFP-Orai1 (top) or eGFP-Orai1 + CAD (bottom). Images are shown at the indicated times after bleaching a bar across the
cell footprint (left). Scale bars represent 5 mm.
(D) Time course of FRAP from single cells expressing eGFP-Orai1 alone (black) or with CAD (red). The superimposed fits indicate diffusion coefficients of
0.12 mm2/s (Orai1) and 0.026 mm2/s (Orai1 + CAD).
(E) Mean diffusion coefficients and mobile fractions of eGFP-Orai1 expressed alone (n = 9) or with CAD (n = 6; means ±SEM).Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc. 887
Figure 7. CRAC Channel Clustering and Activation by STIM1 Are Separable and Require the CAD Region
(A–D) When coexpressed with Orai1, STIM1-DCAD fails to form puncta and cluster Orai1 after store depletion (A). In contrast, STIM11-448 (B), STIM11-440 (C), and
STIM1C437G (D) coaccumulatewithOrai1 inpuncta after storedepletion. Imagesareconfocalmicrographsof theHEK293cell footprint. Scale bars represent 10mm.
(E) Ca2+ measurements (mean ±SEM) in HEK293 cells expressing the indicated constructs. In all cases, Orai1 was tagged with eGFP and the STIM1 or its variant
was tagged with mCherry.
(F) Puncta formation andCa2+ influx in cells expressingOrai1 andSTIM1 variants. Each set of bars shows the fraction of the cell’s STIM1 orOrai1 fluorescence that
is colocalized to puncta before and after store depletion (mean ±SEM, n = 4 cells for each) and the initial rate of Ca2+ entry (dR/dt, where R is the fura-2 350/380
fluorescence ratio) measured 10–20 s after readdition of Ca2+ in (E).888 Cell 136, 876–890, March 6, 2009 ª2009 Elsevier Inc.
For Figure 7, cells were loaded as above with 2 mM fura-2/AM for 25 min.
Ratiometric Ca2+ imaging was performed with 350 and 380 nm excitation in
2mMCa2+Ringer’s solution on anAxiovert 35 invertedmicroscopewith a Video-
Probe imaging systemasdescribed (Bautista et al., 2002). mCherry-positive cells
were identifiedwitha540± 12nmexcitationanda580LPemissionfilter (Chroma).
Electrophysiology
HEK293 cells were transfected 8–24 hr prior to electrophysiology experiments
with STIM1- and Orai1-derived constructs in a 1:1 mass ratio with Lipofect-
amine 2000. Cells transfected with CAD + Orai1 were cultured in 10 mM
LaCl3 to avoid the toxicity of constitutively active ICRAC, and LaCl3 was washed
out immediately before seal formation. ICRAC in cells cultured without LaCl3
was similar to that in cells cultured with LaCl3, but most cells without LaCl3
died soon after break-in.
Currents were recorded via standard whole-cell patch clamp techniques
(Prakriya and Lewis, 2001). Pipettes of resistance 2–5 MU were filled with an
internal solution containing 150 mM Cs aspartate, 8 mM MgCl2, 10 mM
EGTA, and 10 mM HEPES (pH 7.2 with CsOH). Currents were sampled at
5 kHz and filtered at 2 kHz, and all voltages were corrected for the junction
potential of the pipette solution relative to Ringer’s in the bath (13 mV).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and eight
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00152-4.
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